Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

7.34

-0.07 (-0.94%)

At close: Oct 6, 2025, 4:00 PM EDT

7.30

-0.04 (-0.54%)

After-hours: Oct 6, 2025, 7:57 PM EDT

Gyre Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Oct '25 Oct 6, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	667	1,038	1,967	-
Market Cap Growth	-50.20%	-47.22%	-	-
Enterprise Value	614	1,050	1,946	-
Last Close Price	7.34	12.10	25.69	-
PE Ratio	432.35	85.93	-	-
PS Ratio	6.22	9.82	17.34	-
PB Ratio	7.24	10.55	25.07	-
P/TBV Ratio	7.66	16.85	-	-
P/FCF Ratio	-	-	113.23	-
P/OCF Ratio	719.17	-	75.99	-
EV/Sales Ratio	6.01	9.93	17.15	-
EV/EBITDA Ratio	53.54	58.96	95.72	-
EV/EBIT Ratio	65.70	64.73	101.27	-
EV/FCF Ratio	-	-	111.99	-
Debt / Equity Ratio	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.11	0.09	0.02	0.06
Debt / FCF Ratio	-	-	0.02	0.11
Asset Turnover	0.75	0.87	1.13	-
Inventory Turnover	0.58	0.73	0.89	-
Quick Ratio	4.68	2.64	2.49	3.33
Current Ratio	5.40	3.32	2.85	4.06
Return on Equity (ROE)	7.84%	20.24%	-113.45%	-
Return on Assets (ROA)	4.27%	8.38%	11.93%	-
Return on Capital (ROIC)	5.16%	11.34%	15.83%	-
Return on Capital Employed (ROCE)	6.90%	15.30%	19.90%	12.70%
Earnings Yield	0.62%	1.16%	-4.72%	-
FCF Yield	-0.01%	-0.57%	0.88%	-
Buyback Yield / Dilution	-33.83%	-55.39%	13.02%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q